The HIV Seroconversion Study is an ongoing study into the experiences of people in Australia who have recently been diagnosed with HIV. The study aims to understand the factors that lead to HIV infection, and also learn about the experiences of those living with a recent HIV diagnosis.
Across most of Australia, rates of new HIV diagnoses appear to have stabilised over recent years. Data collected through the Seroconversion Study provides vital, up to date information that is used to inform HIV prevention efforts, and ensure that appropriate services are available for those who are recently diagnosed. Crucial to the continuing success of the study is the support of those who have contact with people recently diagnosed, either in a clinical or a community setting, to inform those clients that the study remains actively recruiting. This provides those individuals with the opportunity to contribute their story; ensuring a wide range of experiences are represented in the sample. It’s worth noting that mostly those who participate in the study provide positive feedback, and many say they appreciate the opportunity to tell their story in a way that might help others.
Anyone over the age of 18 who has been diagnosed with HIV in the past two years is eligible to participate in the study. The study has been expanded to include anyone recently diagnosed, not just those recently infected.
The Seroconversion Study is a collaboration between the University of New South Wales and La Trobe University, in association with the health departments and key community stakeholders in all states and the ACT.
Find out more about the study at www.hivss.net
Information in this article is courtesy of Ian Down,Associate Lecturer,
The Kirby Institute, The University of New South Wales and the Australian Research Centre in Sex, Health and Society, La Trobe University
